Coverage
-
February 13, 2018
Eli Lilly and Co. urged a California federal court Monday not to reopen a proposed class action alleging the drugmaker hid the withdrawal risks of the antidepressant Cymbalta, saying the proposed class voluntarily dismissed their suit knowing that a U.S. Supreme Court decision could block them from appealing.
11 other articles on this case.
View all »